Category: Finance
-
Oxford, GSK Partner on New Tech for Neuro Diseases
GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders.
-
$180M Venture Fund Backing Age-Related Disease Start-Ups
A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics.
-
Infographic – 1 in 6 Americans Using Cryptocurrency
A recent survey by Pew Research Center indicates cryptocurrencies are gaining more traction among individuals in the U.S., particularly younger people.
-
Plant-Based Protein Biotech Raises $3M in Seed Funds
A biotechnology start-up producing proteins with more sustainable and less costly plant-based processes is raising $3 million in its seed funding round.
-
Infographic – U.S. Venture Funding States Left Behind
Crunchbase News reported on parts of the U.S. getting the fewest venture dollars, displayed in today’s infographic.
-
Cell Therapy Start-Up Raises $6M in Seed Funds
A new company providing clinical development and commercialization for emerging cell therapies began operations and raised $6 million in seed funding.
-
Novo Nordisk Buys RNA Biotech in $3.3B Deal
Global drug maker Novo Nordisk is acquiring biotechnology company Dicerna Pharmaceuticals Inc. in an all-cash deal valued at $3.3 billion.
-
Synthetic Bio Milk Company Gains $13M in Seed Funds
A start-up enterprise creating milk and dairy products with proteins derived from engineered microorganisms is raising $13 million in seed funds.
-
Small Biz Grant Funds Long-Term Spasticity Implant
A developer of treatments for neurological disorders received National Institutes of Health funding for an implant treating spasticity for up to six months.
-
New Company to Develop Synthetic Antibody Therapies
A new business is underway to develop and commercialize treatments for Covid-19 and other diseases based on synthetic antibody proteins.